Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])
- Status
- COMPLETED
- Phase
- N/A
MAGE-A4ᶜ¹º³²T for Multi-Tumor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Investigating the Clinical Utility of the MDS
- Status
- COMPLETED
- Phase
- N/A
LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
- Status
- UNKNOWN
- Phase
- PHASE1
Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Dendritic Cell Vaccination in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker
- Status
- COMPLETED
- Phase
- PHASE2
Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
A Randomized Controlled Study Comparing Priming Solution Containing Crystalloid or Packed Red Blood Cells in Patients Treated With Isolated Limb Perfusion.
- Status
- COMPLETED
- Phase
- NA
An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase I-c Study of Recombinant GM-CSF Herpes Simplex Virus to TreatⅣ M1c
- Status
- UNKNOWN
- Phase
- N/A
18F-Labeled Picolinamide PET Imaging of Melanoma Diagnosis
- Status
- UNKNOWN
- Phase
- NA